How to buy HCW Biologics stock (HCW Biologics)

HCW Biologics is a biotechnology business based in the US. HCW Biologics shares (HCWB) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.41 – an increase of 6.98% over the previous week. HCW Biologics employs 45 staff and has a trailing 12-month revenue of around $3.9 million.

Our top picks for where to buy HCW Biologics stock

Buy HCW Biologics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

HCW Biologics stock price (NASDAQ: HCWB)

Use our graph to track the performance of HCWB stocks over time.

HCW Biologics shares at a glance

• Key figures

Information last updated 2024-12-15.

Latest market close	$0.41
52-week range	$0.28 - $1.93
50-day moving average more info button	$0.51
200-day moving average more info button	$0.95
Wall St. target price	$3.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.05

Is it a good time to buy HCW Biologics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

HCW Biologics price performance over time

Historical closes compared with the close of $0.3312 from 2024-12-17

1 week (2024-12-13)	-7.23%
1 month (2024-11-20)	-65.03%
3 months (2024-09-19)	-33.76%
6 months (2024-06-18)	-67.53%

1 year (2023-12-19)	-72.85%
2 years (2022-12-19)	-83.68%
3 years (2021-12-17)	2.53
5 years (2019-12-16)	N/A

HCW Biologics financials

Revenue TTM	$3.9 million
Gross profit TTM	$4.1 million
Return on assets TTM	-70.09%
Return on equity TTM	-344.32%
Profit margin	0%
Book value	$-0.17
Market Capitalization more info button	$11.9 million

TTM: trailing 12 months

HCW Biologics share dividends

We're not expecting HCW Biologics to pay a dividend over the next 12 months.

You may also wish to consider:

HCW Biologics share price volatility

Over the last 12 months, HCW Biologics's shares have ranged in value from as little as $0.2761 up to $1.93. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while HCW Biologics's is 0.838. This would suggest that HCW Biologics's shares are less volatile than average (for this exchange).

To put HCW Biologics's beta into context you can compare it against those of similar companies.

• Novavax (NVAX.US): 2.088
• Moderna (MRNA.US): 1.69
• BioNTech (BNTX.US): 0.259

HCW Biologics overview

HCW Biologics Inc. , a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201, a cell-based therapy that is in Phase I clinical trials for the treatment of patients with relapsed/refractory acute myelogenous leukemia; and HCW9206, an injectable immunotherapeutic to use as adjuvant for adoptive cell therapy in cancer treatment. The company was incorporated in 2018 and is headquartered in Miramar, Florida. .

Frequently asked questions

null
What percentage of HCW Biologics is owned by insiders or institutions?
Currently 52.304% of HCW Biologics shares are held by insiders and 3.18% by institutions. How many people work for HCW Biologics?
Latest data suggests 45 work at HCW Biologics. When does the fiscal year end for HCW Biologics?
HCW Biologics's fiscal year ends in December. Where is HCW Biologics based?
HCW Biologics's address is: 2929 North Commerce Parkway, Miramar, FL, United States, 33025 What is HCW Biologics's ISIN number?
HCW Biologics's international securities identification number is: US40423R1059